Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecol… (NCT03260647) | Clinical Trial Compass
CompletedNot Applicable
Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers
Canada96 participantsStarted 2017-08-04
Plain-language summary
Management of Malignant Bowel Obstruction (MBO) in Patients with Advanced Gynecological Cancers
Who can participate
Age range18 Years – 100 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Histologically and /or cytologically confirmed gynecological cancer, including ovarian, fallopian tube, endometrial, cervical or primary peritoneal cancer Deemed to be at risk of developing or have a clinical diagnosis of MBO as defined using the following criteria: clinical evidence of bowel obstruction (history/physical/radiological examination; and bowel obstruction beyond the ligament of Treitz.
Exclusion Criteria:
There are no specified exclusion criteria for this study